Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct:94:106119.
doi: 10.1016/j.ijsu.2021.106119. Epub 2021 Sep 16.

Intranasal COVID-19 vaccines: Is it a boon or bane?

Affiliations

Intranasal COVID-19 vaccines: Is it a boon or bane?

Om Prakash Choudhary et al. Int J Surg. 2021 Oct.
No abstract available

Keywords: Advantages; COVID-19; Disadvantages; Immunity; Intranasal; SARS-CoV-2; Vaccines.

PubMed Disclaimer

Conflict of interest statement

All authors report no conflicts of interest relevant to this article.

Figures

Fig. 1
Fig. 1
Schematic model of the potential effect of nasal vaccines on the upper and lower respiratory tract for the generation of mucosal and systemic immunity.(A) Protective immune responses in the nasopharynx-associated lymphoid tissue (NALT), with the virus-mediated reaction resulting mainly from secretory IgA antibodies generated by mucosal epithelial cells. (1) M cells actively take up antigens or penetrate epithelial junctions passively (2), DCs that extend into the lumen also take up antigens. (3). DCs acquire antigens and transport them to nearby lymphoid follicles or lymph nodes, where they are presented to CD4+ T-cells (4). CD4+ T cells activated by DCs activate naive B cells, causing them to switch isotype and become antigen-specific IgA+ committed B cells (5). These IgA+ B cells migrate from the lymph node to the blood circulations (6). Finally, IgA+ B cells exit the blood and enter towards the effector site. They undergo final differentiation and maturations producing IgA+ plasma cells (process enhanced by IL-5 and IL-6, a subset of Th2 cells) and ultimately form dimeric or polymeric IgA (7). The dimeric or polymeric IgA binds with pIgR in the basolateral region to form sIgA (8) and further transcytoses towards the apical side of the luminal surface (9). (B) Humoral immune response in the lower respiratory tract with bronchus-associated lymphoid tissue (BALT) having humoral as well as mucosal/local immune responses. DC: Dendritic cell; IL: Interleukin; M cell: Microfold cell; pIgR: Polymeric immunoglobulin receptor; sIgA: Secretory IgA; Th: T-helper cell.

References

    1. Kyriakidis N.C., López-Cortés A., Vásconez González E., Barreto Grimaldos A., Ortiz Prado E. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines. 2021;6:28. doi: 10.1038/s41541-021-00292-w. - DOI - PMC - PubMed
    1. Gamerra M., de Corso E., Cantone E. COVID-19: the crucial role of the nose. Braz. J. Otorhinolaryngol. 2021;87(1):118–119. doi: 10.1016/j.bjorl.2020.08.001. - DOI - PMC - PubMed
    1. Zhao J., Zhao J., Mangalam A.K., Channappanavar R., Fett C., Meyerholz D.K., Agnihothram S., Baric R.S., David C.S., Perlman S. Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity. 2016;44(6):1379–1391. doi: 10.1016/j.immuni.2016.05.006. - DOI - PMC - PubMed
    1. Wake A.D. The willingness to receive COVID-19 vaccine and its associated factors: “vaccination refusal could prolong the war of this pandemic”- a systematic review. Risk Manag. Healthc. Pol. 2021;14:2609–2623. doi: 10.2147/RMHP.S311074. - DOI - PMC - PubMed
    1. Lund F.E., Randall T.D. Scent of a vaccine. Science. 2021;373(6553):397–399. doi: 10.1126/science.abg9857. - DOI - PubMed

Substances